Navigation Links
Ridge Diagnostics, Inc. Awarded Phase 2 National Science Foundation Grant
Date:4/23/2009

Grant Supports First Blood Test for Depression

SAN DIEGO, April 23 /PRNewswire/ -- Ridge Diagnostics, Inc., a neurodiagnostic company commercializing its first-in-class, proprietary blood test for depression or Major Depressive Disorder(MDD), has been awarded a Phase 2, National Science Foundation, Small Business Innovation Research (SBIR) Program grant. The grant will be used to further the clinical development and commercialization of its blood test for depression, the first blood test for any neuropsychiatric disorder.

In January 2009, the company completed the commercial launch of its CLIA certified laboratory in Research Triangle Park, NC. The laboratory provides testing information to physicians, pharmaceutical companies and clinical research organizations. The test can be used in pharmaceutical research to objectively identify and stratify patient populations to enhance drug research and clinical studies. It is intended to be used by psychiatrists and primary care physicians to diagnose and monitor treatment of patients with depression. A biological test based upon the physiological changes caused by depression could drive the earlier diagnosis, and treatment management of the over 20 million adults in the U.S. facing this disease.

"We are pleased to once again, announce the National Science Foundation's recognition of Ridge's technological accomplishments. This prestigious grant will enable us to further the clinical development of our blood tests and build on our CLIA laboratory infrastructure to support our growing business," stated Stan Sewitch, President and CEO of Ridge.

Ridge Diagnostics, Inc. is a neurodiagnostic company commercializing a breakthrough, first-in-class, proprietary blood test for the diagnosis and treatment monitoring of Major Depressive Disorder (MDD). The company's products are derived from a proprietary Human Biomarker Library and Hype
'/>"/>

SOURCE Ridge Diagnostics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Parkinsons Disease Foundation Awards $300,000 in Bridge Funding for Innovative Research Projects
2. Cambridge Laboratories Announces Approval of Tetrabenazine in Spain
3. Taligen Therapeutics Initiates Corporate Growth Plan with Appointment of Abbie Celniker, Ph.D., as CEO and Establishment of Cambridge, Mass., Headquarters
4. Thoratec Announces FDA Approval of HeartMate II(R) for Bridge-To-Transplantation
5. Free Prostate Cancer Seminar in Lake Ridge, VA: Dr. Charles Snuffy Myers Announces Vitamin D Clinical Trials
6. Vermillion Renews Strategic Alliance Agreement With Quest Diagnostics, Inc.
7. Pressure BioSciences, Inc. Announces $850,000 NIH SBIR Phase II Award for the Development of a New PCT-dependent System for Improved Biomarker Discovery, Diagnostics, and Drug Discovery
8. Global Health Research Foundation Awarded $25,000 Grant From Westly Foundation to Study Asthma in Californias Central Valley
9. KGI Professor Ian Phillips Awarded Defense Grants for Medical Combat Research
10. K-State Researchers Awarded Nearly $1 Million to Test Remedies, Investigate Link Between E. Coli and Distillers Grains
11. Modigene Awarded Israeli Government Grant to Support Development of Its Longer-Acting Interferon Beta
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)... Inc., a wholly-owned subsidiary of Volcano Corporation (Nasdaq: ... testing of a novel integrated light source architecture for ... design raises the bar on imaging speed and overcomes ... light sources. This approach to optical engines builds ...
(Date:12/4/2009)... Dec. 4 Watson Pharmaceuticals, Inc. (NYSE: ... confirmed that its subsidiary, Watson Laboratories, Inc.-Florida, filed an ... and Drug Administration seeking approval to market its 8mg ... owned by Takeda Pharmaceutical Company Limited. Watson,s 8mg ...
(Date:12/4/2009)... Drs. Neal Shore and E. David Crawford presented ... analysis of secondary end points of biochemical recurrence rate ... degarelix for injection) or monthly leuprolide in prostate cancer ... cancer patients who received FIRMAGON 240/80 mg/month had a ...
Breaking Medicine Technology:Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 2Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 3Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 4Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 5Watson Files FDA Application for Generic Rozerem(R) 2Watson Files FDA Application for Generic Rozerem(R) 3Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 2Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 3Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 4Common household pesticides linked to childhood cancer cases in Washington area 52920 1Common household pesticides linked to childhood cancer cases in Washington area 52920 2Biologists rediscover endangered frog population 9389 1Biologists rediscover endangered frog population 9389 2Biologists rediscover endangered frog population 9389 3Biologists rediscover endangered frog population 9389 4MSA Announces Second Quarter Results 52918 1MSA Announces Second Quarter Results 52918 2MSA Announces Second Quarter Results 52918 3MSA Announces Second Quarter Results 52918 4MSA Announces Second Quarter Results 52918 5MSA Announces Second Quarter Results 52918 6MSA Announces Second Quarter Results 52918 7MSA Announces Second Quarter Results 52918 8
... a new study, men with,locally recurrent prostate cancer ... treatment option., A Phase III clinical trial ... is investigating the safety and efficacy of High ... recurrent prostate,cancer following failed external beam radiation therapy ...
... Institute and Gallo Research Center today announced ... (SoRI-9409) will be published in the December ... publication is available online,today at the journal,s ... that,causes selective and long-lasting reduction in ethanol ...
Other Medicine Technology:High Intensity Focused Ultrasound for Locally Recurrent Prostate Cancer Following External Beam Radiation Therapy Investigated in Phase III Clinical Study 2Novel Compound Shows Promise for Treatment of Alcoholism 2Novel Compound Shows Promise for Treatment of Alcoholism 3Novel Compound Shows Promise for Treatment of Alcoholism 4
(Date:12/7/2009)... years ago, lead paint in toys manufactured in ... in the USA. This fall, news of Baby ... are suspect. Renowned parenting expert Dr. Jeffrey Fine, ... to developing brains, retarding language development and shortening ... of separation, which is the defining trait of ...
(Date:12/7/2009)... National Health Service (NHS), which manages 500 hospitals and ... value of an engaged staff: healthier and happier patients. ... value of care, many NHS hospitals are teaming up ... to train hospital leaders. ,, "Staff engagement is essential ... Steven Weeks, policy manager for NHS Employers, an organisation ...
(Date:12/7/2009)... -- With more than 500,000 customers worldwide, the ... for people and their pets, Native Remedies, has ... record. The company,s two brands, Native Remedies ( ... complete lines of safe, scientifically-tested, guaranteed products that ... "Our publicity will introduce Native Remedies and PetAlive ...
(Date:12/7/2009)... has begun his work as the new worldwide executive director ... ... Horsham, PA, USA (Vocus) December 4, 2009 -- ... begun his work as the new worldwide executive director of ... vice president of the American Society of Plastic Surgeons (ASPS). ...
(Date:12/7/2009)... -- Today the Centers for Disease Control and Prevention ... While the week was designed to highlight the importance ... importance of taking additional steps to keep you and ... season of December, January and beyond. ,, "It,s easy ... the topic of both seasonal and swine flu," said ...
Breaking Medicine News(10 mins):Health News:Top 10 Toys That Will Scar Your Child for Life 2Health News:The NHS to Improve Patient Care by Better Engaging Staff 2Health News:Native Remedies and PetAlive.com Hires TransMedia Group to Herald Herbal for People and Pets 2Health News:New DIA Vision And Mission Coincides With Start of Paul Pomerantz Tenure As Worldwide Executive Director 2Health News:New DIA Vision And Mission Coincides With Start of Paul Pomerantz Tenure As Worldwide Executive Director 3Health News:As CDC Kicks Off National Influenza Vaccination Week, It Is More Important than Ever to Take Preventative Measures Against Cold & Flu 2Health News:As CDC Kicks Off National Influenza Vaccination Week, It Is More Important than Ever to Take Preventative Measures Against Cold & Flu 3
... Medicine and Allergy, University Hospital, Sweden and his collaborators ... increased inflammation response in the lungs of the exposed ... pathways and openings and when they analyzed the inflammatory ... found a decreased inflammatory cells which they feel is ...
... by the stress that is caused by disasters like ... ones that manage to survive will have a longer ... researchers belonging to the University of California. Female foetuses ... ,Mothers' bodies under stress have less tolerance for ...
... to damage. And a new study says just that.,Due ... a catastrophic collapse in orangutan populations// living in the ... Malaysia. Benoit Goossens, Lounès Chikhi, ,The ... within the past hundred years. The massive effects were ...
... discovered that the key to visual awareness is located in ... It has always puzzled scientists as to how the human ... ,Now researchers say that this power ... at the back of the brain. Stephen Macknik, Ph.D., a ...
... can be used to clean the land which has been ... University of York. The team led by the University of ... bacterial micro- // organism in the soil in land contaminated ... of nitrogen for growth. ,However, on finding ...
... year was 2005, according to a NASA analysis. The other ... in the Artic region, the year 2005 was reportedly unusually ... temperature data from weather // stations on land, satellite measurements ... for earlier years. ,They found that a ...
Other Medicine News:
Determination of the Thrombin Time by STA Analyzers. Freeze-dried human thrombin (1.5NIH units/mL) with calcium....
Quantitative determination of Fibrinogen (Clauss Method). Freeze-dried human thrombin (~100NIH units/mL) with heparin inhibitor and calcium....
Determination of Prothrombin Time (PT) by STA Analyzers (ISI~1.3).Freeze-dried rabbit brain thromboplastin with heparin inhibitor....
Determination of Prothrombin Time (PT)by STA Analyzers (ISI~1.8).Freeze-dried rabbit brain thromboplastin with heparin inhibitor....
Medicine Products: